Author | Joaquim Bellmunt, MD, PhD | OncLive

Author | Joaquim Bellmunt, MD, PhD

Articles

Dr. Bellmunt Highlights Immunotherapy Options in Bladder Cancer

January 04, 2019

Video

Joaquim Bellmunt, MD, PhD, genitourinary oncologist, Beth Israel Deaconess Medical Center, associate professor of medicine, Harvard Medical School, differentiates between immunotherapy options available for the treatment of patients with in bladder cancer.

Dr. Bellmunt on The Cancer Genome Atlas Project in Bladder Cancer

April 05, 2018

Video

Joaquim Bellmunt, MD, PhD, associate professor of medicine, Harvard Medical School, director, Bladder Cancer Center, Dana-Farber Cancer Institute, discusses The Cancer Genome Atlas (TCGA) project in bladder cancer.

Dr. Bellmunt on Immunotherapy Combination Trials in Bladder Cancer

March 28, 2018

Video

Joaquim Bellmunt, MD, PhD, associate professor of medicine, Harvard Medical School, director, Bladder Cancer Center, Dana-Farber Cancer Institute, discusses trials investigating combinations with immunotherapy for patients with bladder cancer.

Dr. Bellmunt on PD-L1 Data in Bladder Cancer

March 13, 2018

Video

Joaquim Bellmunt, MD, PhD, associate professor of medicine, Harvard Medical School, director, Bladder Cancer Center, Dana-Farber Cancer Institute, discusses PD-L1 data with pembrolizumab (Keytruda) in patients with bladder cancer.

x